Patents Represented by Attorney, Agent or Law Firm Elias J. Lambins, Esq.
  • Patent number: 6270968
    Abstract: A method for providing a hybrid polypeptide having an activity of interest, by i) performing PCR amplification using an uncharacterized DNA sample and oligonucleotide primers with homology to one or more known genes encoding a polypeptide exhibiting said activity of interest, to obtain one or more PCR products, ii) linking the obtained PCR products to a 5′ structural gene sequence and a 3′ structural gene sequence, wherein the 5′ and 3′ structural gene sequences are derived from one or more genes encoding a polypeptide exhibiting said activity of interest, to form hybrid DNA sequences, iii) expressing the resulting hybrid DNA sequences, and iv) screening the hybrid polypeptides to identify a sequence encoding a polypeptide exhibiting said activity of interest or a related activity.
    Type: Grant
    Filed: November 5, 1998
    Date of Patent: August 7, 2001
    Assignee: Novozymes A/S
    Inventors: Henrik Dalbøge, Thomas Sandal, Markus Sakari Kauppinen, Børge Diderichsen
  • Patent number: 6268329
    Abstract: This invention relates to an enzyme containing granular composition comprising: a) an enzyme containing core and b) a protective substantially continuous layer or coating encapsulating the core comprising at least 60% of a water soluble compound, having a molecular weight below 500 grams per mole, a pH below 11 and a constant humidity at 20° C. of more than 81%. The invention provides an improved stability of enzymes upon storage.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: July 31, 2001
    Assignee: Nouozymes A/S
    Inventor: Erik Kjær Markussen